Loading clinical trials...
Loading clinical trials...
The NODE-202 Study Multi-Center, Multi-National, Open-Label, Efficacy and Safety Study of Etripamil Nasal Spray in Pediatric Patients With Paroxysmal Supraventricular Tachycardia
Conditions
Interventions
Etripamil NS
Locations
10
United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
Advocate Children's Hospital
Oak Lawn, Illinois, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Oregon Health and Science University
Portland, Oregon, United States
Le Bonheur Children's Hospital
Memphis, Tennessee, United States
Baylor College of Medicine
Houston, Texas, United States
Start Date
December 11, 2023
Primary Completion Date
June 1, 2027
Completion Date
June 30, 2027
Last Updated
August 1, 2025
NCT05820035
NCT06327425
NCT03042078
NCT01655316
Lead Sponsor
Milestone Pharmaceuticals Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions